Bryan, Garnier & Co's News

Novo Nordisk: Tresiba and Ryzodeg approved in the US

NEUTRAL, Fair Value DKK390 (+5%)
News published on
September Monday 28, 2015



For more information, please contact marketing@bryangarnier.com